TOXICOLOGY: TUMOR MARKES Flashcards

1
Q

____ is a group of more than 100 diseases that develop
across time and involve the uncontrolled division of the
body’s cells

A

Cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

formation of tumor

A

🔊Tumorigenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the spreading of tumor

A

🔊Metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Also called, mass of cells, formed of these abnormal cells
may remain within the tissue in which it originated (a
condition called in situ cancer), or it may begin to invade
nearby tissues (a condition called invasive cancer).

A

TUMOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

An invasive tumor is said to be____, and cells shed
into the blood or lymph from a malignant tumor are likely
to establish new tumors (metastases) throughout the body

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TUMOR MARKERS

A

🔊Other term: Cancer Marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

___ are measurable biochemicals that are
associated with a malignancy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Formation of New Blood Vessels

A

Angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

From the Greek word___, meaning vessel, the
formation of blood vessels from existing vasculature.

A

Angêion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Programmed Cell Death

A

Apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Apoptosis
Biochemical Events:

A

○ Blebbing, cell shrinkage, nuclear fragmentation,
chromatin condensation, chromosomal DNA
fragmentation, and global mRNA decay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Apoptosis results when the ___) break down

A

cytoskeleton (by proteases)
and DNA (by endonucleases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phases of cell activity divided into Growth, DNA
Synthesis and Mitosis.

A

Cell Cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chromosome duplication occurs during the ___of the
cell cycle, whereas most other cell components are
duplicated continuously throughout the cycle.

A

S phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

During ___, the replicated chromosomes are
segregated into individual nuclei (mitosis), and the cell
then splits in two (cytokinesis).

A

M phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Encodes a protein that promotes uncontrolled cell growth
when mutated

A

ONCOGENE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Uncontrolled tissue growth
● Malignant or Benign

A

NEOPLASM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

🔊As the disease progresses, both proliferation & metastasis occur
at expense of normal organ processes.

A

🔊Stage 1: Localized Primary Tumor
➔ Only one is affected
🔊Stage 2: Invasion of Primary Tumor through Epithelium and into
Blood Vessels 🔊Stage 3: Migration of Tumor into Regional Lymph Node
➔ Liver in cancer but lymph nodes are affected
🔊Stage 4: Metastasis & Invasion of Tumor to Distant Tissues
➔ Lung cancer but it reached the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tumor marker concentration generally elevates during the
progression of tumor

A

Prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Types of Tumor Markers

A

Enzyme
Serum protein
Endocrine (Hormones)
Carbohydrate & Cancer Antigen
Receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prostate-Specific Antigen
● Tumor type:
● Clinical importance:

A

● Tumor type: Prostate cancer
● Clinical importance: Prostate cancer screening, therapy
monitoring, recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

LD
● Tumor type:
● Clinical importance:

A

● Tumor type: HEMATOLOGIC MALIGNANCIES
● Clinical importance:prognostic indicator, elevated
non-specifically in numerous CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ALP
● Tumor type:
● Clinical importance:

A

● Tumor type: Metastatic bone CA, hepatocellular CA
(found in the liver) , osteosarcoma (for the bone),
lymphoma, leukemia
● Clinical importance:determination of liver and bone
involvement; nonspecific elevation in many bone related
and liver cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Neuron-Specific Enolase
● Tumor type:
● Clinical importance:

A

● Tumor type: : Neuroendocrine tumors
● Clinical importance:Prognostic indicator and monitoring
disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Neuron-Specific Enolase
🔊Method

A

is Radioimmunoassay & Immunohistochemistry

26
Q

ENZYME MARKERS ARE

A

PSA
LD
ALP
NSE

27
Q

SERUM PROTEIN MARKERS

A

-Serum M-Protein
-Serum Free Light Chains
-Beta2- Microglobulin

28
Q

Serum M-Protein
● Tumor type:
● Clinical importance

A

● Tumor type: Plasma cell dyscrasias
● Clinical importance: diagnosis and therapeutic
monitoring

29
Q

Serum Free Light Chains
● Tumor type:
● Clinical Importance:

A

● Tumor type: Plasma cell dyscrasias
● Clinical Importance: Diagnosis and therapeutic
monitoring

30
Q

Beta2- Microglobulin
Tumor type: Hematologic malignancies
● Clinical Importance: Prognostic marker for
lymphoproliferative disorders

A

Tumor type:
Clinical Importance:

31
Q

Endocrine Tumor Markers

A

-ACTH
-ADH
-C-PEPTIDE
-CALCITIONIN
-CHROMOGRANIN A
-CORTISOL
-GASTRIN

32
Q

ACTH
● Tumor type:
tumor
● Clinical importance:

A

● Tumor type: Pituitary adenoma, ectopic ACTH-producing
tumor
● Clinical importance: Ectopic ACTH-producing tumor

33
Q

ADH
● Tumor type:
● Clinical Importance:

A

● Tumor type: Posterior pituitary tumors
● Clinical Importance: SIADH

34
Q

C- Peptide
● Tumor type:
● Clinical Importance:

A

● Tumor type: Insulin-secreting tumors 🔊Or tumors secreting insulin
● Clinical Importance: Insulinoma

35
Q

Calcitonin
● Tumor type:
● Clinical importance:

A

● Tumor type: MTC (Medullary Thyroid Carcinoma)
● Clinical importance: Screening, response to therapy, and
monitoring recurrence of MTC

36
Q

Chromogranin A
● Tumor type:
● Clinical importance:

A

● Tumor type: Pheochromocytoma, neuroblastoma,
carcinoid tumors, small lung cancers
● Clinical importance: Aid in the diagnosis of carcinoid
tumors, pheochromocytoma, & neuroblastomas

37
Q

Cortisol
● Tumor type:
● Clinical importance:

A

● Tumor type: Adrenal tumors
● Clinical importance: Diagnosis of Cushing’s syndrome,
adrenal adenoma

38
Q

Gastrin
● Tumor type:
● Clinical importance:

A

● Tumor type: neuroendocrine tumor
● Clinical importance: Prognostic marker for
Lymphoproliferative disorders

39
Q

Frequently Ordered Tumor Markers
🔊Usually requested tumor markers in the laboratory

A
  1. AFP
  2. Ca125
  3. CEA
  4. hCG
  5. PSA
40
Q

Abundant carcinoembryonic serum protein

A

AFP

41
Q

AFP peaks a____
weeks gestation

A

1/10 the concentration of albumin at 30

42
Q

Subtypes of Testicular CA

A

● Seminomatous Tumor
● Nonseminomatous Tumor
○ Differentiate into embryonal CA, teratoma,
choriocarcinoma, and yolk sac tumors

43
Q

○ Differentiate into embryonal CA, teratoma,
choriocarcinoma, and yolk sac tumors

A

● Nonseminomatous Tumor

44
Q

○ Directly forms from malignant germ cells

A

● Seminomatous Tumor

45
Q

Marker for Colorectal CA
● Utilized in combination with histology & TNM staging
system

A

CEA

46
Q

HCG
Normally secreted by____ to maintain the corpus
luteum through the 1st trimester of pregnancy

A

trophoblasts

47
Q

Prognostic indicator for ovarian CA
● Diagnostic marker for testicular CA
● Most useful marker for detection of gestational
trophoblastic diseases

A

HCG

48
Q

Hepatic & Testicular CA

A

AFP

49
Q

Lung Cancer

A

ALP

50
Q

Pancreatic CA

A

Amylase

51
Q

Breast & Ovarian Cancer

A

BRCA-1

52
Q

Breast Cancer/ (Ovarian
Cancer)

A

CA 125

53
Q

Breast Cancer

A

CA 15-3

54
Q

Gastric, pancreatic, & colorectal CA

A

CA 19-9

55
Q

Gastric & Pancreatic CA

A

CA-50

56
Q

Breast CA

A

CA 27.29 , Cathepsin-D & ESTROGEN RECPETOR

57
Q

Breast, Lung, Colorectal, & Stomach
CA

A

CEA

58
Q

Small cell lung CA; prostate CA

A

CK-1

59
Q

Hepatoma

A

GGT

60
Q

Urinary Bladder CA

A

Nuclear Matrix
Protein